A stochastic model for PSA levels: behavior of solutions and population statistics

This paper investigates the partial differential equation for the evolving distribution of prostate-specific antigen (PSA) levels following radiotherapy. We also present results on the behavior of moments for the evolving distribution of PSA levels and estimate the probability of long-term treatment success and failure related to values of treatment and disease parameters. Results apply to a much wider range of parameter values than was considered in earlier studies, including parameter combinations that are patient specific.

[1]  I. Kaplan,et al.  Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate. , 1994, International journal of radiation oncology, biology, physics.

[2]  E. Messing,et al.  Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Murray,et al.  A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth: an explanation for a medical anomaly. , 2001, The American journal of pathology.

[4]  A. Friedman.  Partial Differential Equations of Parabolic Type , 1983 .

[5]  Thomas L. Jackson,et al.  A mathematical model of prostate tumor growth and androgen-independent relapse , 2003 .

[6]  T. Wheldon.  Mathematical models in cancer research , 1988 .

[7]  H. Risken.  The Fokker-Planck equation : methods of solution and applications , 1985 .

[8]  Menggang Yu,et al.  JOINT LONGITUDINAL-SURVIVAL-CURE MODELS AND THEIR APPLICATION TO PROSTATE CANCER , 2004 .

[9]  K. Griffith,et al.  Definitions of biochemical failure in prostate cancer following radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[10]  J. T. Kemper,et al.  A stochastic model for prostate-specific antigen levels. , 2004, Mathematical biosciences.

[11]  D. Veestraeten.  An alternative approach to modelling relapse in cancer with an application to adenocarcinoma of the prostate. , 2006, Mathematical biosciences.

[12]  I. I. Gikhman,et al.  The Theory of Stochastic Processes III , 1979 .

[13]  Valery Stohny,et al.  Symmetry Properties and Exact Solutions of the Fokker-Planck Equation , 1997 .

[14]  N. Yang,et al.  Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. , 1985, Cancer research.

[15]  R. Dunn,et al.  Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. , 2000, International journal of radiation oncology, biology, physics.

[16]  I. Kaplan,et al.  Prostate specific antigen after irradiation for prostatic carcinoma. , 1990, The Journal of urology.

[17]  I. Kaplan,et al.  A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy , 1991, Cancer.

[18]  I. Kaplan,et al.  Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. , 1993, The Journal of urology.

[19]  Steven H. Strogatz,et al.  Nonlinear Dynamics and Chaos , 2024 .

[20]  Ram Rup Sarkar,et al.  Cancer self remission and tumor stability-- a stochastic approach. , 2005, Mathematical biosciences.

[21]  P W A Dayananda,et al.  Prostate cancer: progression of prostate-specific antigen after external beam irradiation. , 2003, Mathematical biosciences.

[22]  Jeremy M G Taylor,et al.  The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. , 2002, Biostatistics.

[23]  C. Landmann,et al.  Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer. , 1989, International journal of radiation oncology, biology, physics.

[24]  G. Shenouda,et al.  No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy. , 2006, Urology.

[25]  K. Russell,et al.  Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy. , 1991, The Journal of urology.

[26]  R. Babaian,et al.  Prostate‐Specific Antigen and External Beam Radiation Therapy in Prostate Cancer , 1991, Cancer.